A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis. 2015

Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
Klinik für Dermatologie, Venerologie und Allergologie St. Josef-Hospital, Ruhr-Universität Bochum, Bochum, Germany.

BACKGROUND Topical therapy is important in the treatment of actinic keratosis, but guidance for improving adherence/persistence during topical therapy is still lacking. OBJECTIVE To utilize expert consensus to generate a list of recommendations to improve real-world efficacy when prescribing topical therapy for actinic keratosis. METHODS An expert panel of eight dermatologists was convened to generate recommendations based on facilitated discussion and consensus generation using a modified Delphi session. The recommendations were ratified with the expert panel. RESULTS Facilitated discussion generated 31 issues within five themes, which were prioritized using expert voting. Consensus was achieved on the importance of short and simple treatment regimens for maximizing patient compliance, physician awareness of the progression of actinic keratosis to squamous cell carcinoma, provision of appropriate patient information, and the use of effective communication strategies to educate physicians about actinic keratosis. Based on these key findings, eight recommendations were generated. CONCLUSIONS The recommendations will assist physicians when prescribing topical actinic keratosis therapy. Further research should focus on the types of patient outcomes that are influenced by the characteristics of topical field therapy.

UI MeSH Term Description Entries
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D055623 Keratosis, Actinic White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA. Actinic Keratosis,Actinic Keratoses,Keratoses, Actinic

Related Publications

Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
November 2016, The British journal of dermatology,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
November 2016, The British journal of dermatology,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
January 2013, Patient preference and adherence,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
September 2021, Clinical drug investigation,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
September 2015, Journal of the European Academy of Dermatology and Venereology : JEADV,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
January 2019, Journal of the European Academy of Dermatology and Venereology : JEADV,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
January 2016, Acta dermato-venereologica,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
March 2016, Acta dermato-venereologica,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
April 2009, Cutis,
Eggert Stockfleth, and Ketty Peris, and Carlos Guillen, and Rino Cerio, and Nicole Basset-Seguin, and Peter Foley, and José Sanches, and Alex Culshaw, and Sandra Erntoft, and Mark Lebwohl
May 2022, JID innovations : skin science from molecules to population health,
Copied contents to your clipboard!